Re: Overview of Pipeline as of 2019

Posted by undopaminergic on February 20, 2020, at 3:47:34

In reply to Re: Overview of Pipeline as of 2019 » Lamdage22, posted by Jadde on February 19, 2020, at 15:01:22

> > https://www.phrma.org/-/media/Project/PhRMA/PhRMA-Org/PhRMA-Org/PDF/MID_Mental-Illness-2019-Drug-List_Final.pdf
>
> Wow, thats a nice long list! Anything there we should be super excited about, in particular?
>
Especially the kappa-opioid receptor antagonists, in particular because these would be the first in their class to be approved/marketed.
The reuptake inhibitors that act on dopamine are also of some interest, although we already have methylphenidate.
-undopaminergic

Thread

Overview of Pipeline as of 2019 Lamdage22 2/19/20
Re: Overview of Pipeline as of 2019 » Lamdage22 Jadde 2/19/20
Re: Overview of Pipeline as of 2019 undopaminergic 2/20/20
Re: Overview of Pipeline as of 2019 Lamdage22 2/20/20

Post a new follow-up

Notify the administrators

Start a new thread

poster:undopaminergic thread:1108557
URL: http://www.dr-bob.org/babble/20200104/msgs/1108586.html

	for
in